Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Impact of genetic factors (CYP2C9, VKORC1 and CYP4F2) on warfarin dose requirement in the Turkish population.

Özer M, Demirci Y, Hizel C, Sarikaya S, Karalti İ, Kaspar Ç, Alpan S, Genç E.

Basic Clin Pharmacol Toxicol. 2013 Mar;112(3):209-14. doi: 10.1111/bcpt.12024. Epub 2012 Dec 6.

2.

Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?

Bartlett G, Zgheib N, Manamperi A, Wang W, Hizel C, Kahveci R, Yazan Y.

Curr Pharmacogenomics Person Med. 2012;10(2):101-105. No abstract available.

3.

Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA).

Ozdemir V, Rosenblatt DS, Warnich L, Srivastava S, Tadmouri GO, Aziz RK, Reddy PJ, Manamperi A, Dove ES, Joly Y, Zawati MH, Hızel C, Yazan Y, John L, Vaast E, Ptolemy AS, Faraj SA, Kolker E, Cotton RG.

Curr Pharmacogenomics Person Med. 2011 Dec 1;9(4):243-251. No abstract available.

4.

Localization of human BRCA1 and BRCA2 in non-inherited colorectal carcinomas and matched normal mucosas.

Bernard-Gallon DJ, Peffault de Latour M, Hizel C, Vissac C, Cure H, Pezet D, Dechelotte PJ, Chipponi J, Chassagne J, Bignon YJ.

Anticancer Res. 2001 May-Jun;21(3B):2011-20.

PMID:
11497291
5.

BRCA2 protein expression in sporadic breast carcinoma with or without allelic loss of BRCA2.

Bernard-Gallon D, Peffault De Latour M, Rio P, Favy D, Hizel C, Vissac C, Bignon YJ.

Int J Cancer. 2000 May 15;86(4):453-6.

6.

Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines.

Favy DA, Rio P, Maurizis JC, Hizel C, Bignon YJ, Bernard-Gallon DJ.

Biochem Biophys Res Commun. 1999 May 10;258(2):284-91.

PMID:
10329379
7.

Subcellular localization of BRCA1 protein in sporadic breast carcinoma with or without allelic loss of BRCA1 gene.

Bernard-Gallon DJ, De Latour MP, Rio PG, Penault-Llorca FM, Favy DA, Hizel C, Chassagne J, Bignon YJ.

Int J Oncol. 1999 Apr;14(4):653-61.

PMID:
10087311
8.

Isolation, purification and quantification of BRCA1 protein from tumour cells by affinity perfusion chromatography.

Hizel C, Maurizis JC, Rio P, Communal Y, Chassagne J, Favy D, Bignon YJ, Bernard-Gallon DJ.

J Chromatogr B Biomed Sci Appl. 1999 Jan 22;721(2):163-70.

PMID:
10052688
9.

BRCA1 is localized in ductal secretions of normal breast tissues: Detection by antibodies raised against the amino terminus of BRCA1 (K-18)

Bernard-Gallon DJ, Peffault de Latour M, De Oliveira F, Rio P, Hizel C, Favy D, Bignon YJ.

Int J Cancer. 1998 Aug 31;77(5):803-6. No abstract available.

10.

Electrophoresis of BRCA1 oncosuppressor.

Bernard-Gallon D, De Oliveira F, Favy D, Hizel C, Maurizis JC, Rio P, Bignon YJ.

Oncol Rep. 1998 Jul-Aug;5(4):995-7.

PMID:
9625861
11.

Evaluation of the 5' spliced form of human cathepsin B mRNA in colorectal mucosa and tumors.

Hizel C, Ferrara M, Cure H, Pezet D, Dechelotte P, Chipponi J, Rio P, Bignon YJ, Bernard-Gallon D.

Oncol Rep. 1998 Jan-Feb;5(1):31-4.

PMID:
9458288

Supplemental Content

Support Center